Katherine is responsible for data-driven analyses on the innovation economies that SVB serves. In this role, she supports global research efforts that explore investment, fundraising, and exit dynamics in the venture ecosystem. Prior to SVB, Katherine spent time at the intersection of basic and clinical research, studying the neurodevelopmental effects of opioids in newborns to advance treatment strategies. She graduated with high honors from Dartmouth College, receiving a B.A. in neuroscience.